drugset / Trial / NCT01427972
A Study of LY2623091 in Male and Females With Chronic Kidney Disease
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this trial is to investigate the safety and efficacy of LY2623091 in males and females with chronic kidney disease.
Timeline
- Start
- 2011-09
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Eplerenone | Unknown | 50 mg | Oral |
| Subject | LY2623091 | Small molecule | 0.2 mg | Oral |
| Subject | LY2623091 | Small molecule | 1.5 mg | Oral |
| Subject | LY2623091 | Small molecule | 10 mg | Oral |